DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. Funding Opportunities
  3. Synopsis of Open Program Funding Opportunities

Funding Opportunities

Synopsis of Open Program Funding Opportunities


FY22 Bone Marrow Failure Research Program (BMFRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award (IDA) Program Announcement
Application Instructions 		May 5, 2022
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $450,000 in direct costs (plus indirect costs).
 Pre-Application (Preproposal): June 29, 2022
5:00 p.m. Eastern Time (ET)

Application: September 23, 2022 11:59 p.m. ET
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions 		May 5, 2022 Funding Level 1:
  • The maximum period of performance is 3 years.
  • Maximum funding of $600,000 in direct costs (plus indirect costs).

Funding Level 2: IND-enabling efforts
  • The maximum period of performance is 2  years.
  • Maximum funding of $800,000 in direct costs (plus indirect costs).
 Pre-Application (Preproposal): June 29, 2022
5:00 p.m. Eastern Time (ET)

Application: September 23, 2022 11:59 p.m. ET

FY22 Breast Cancer Research Program (BCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Breakthrough Award Levels 1 and 2 II (BTA12-2) Program Announcement
Application Instructions		 June 9, 2022 Funding Level 1:
  • Maximum funding of $450,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 1 with Partnering PI Option:

  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2:

  • Maximum funding of $1 million (M) for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2 – Population Science and Prevention Studies:

  • Maximum funding of $1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.

Funding Level 2 with Partnering PI Option:

  • Maximum funding of $1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2 – Population Science and Prevention Studies – Partnering PI Option:

  • Maximum funding of $2M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
September 22, 2022 5:00 p.m. Eastern Time

Application:
October 6, 2022 11:59 p.m. Eastern Time
Era of Hope Scholar Award II (EOHS-2) Program Announcement
Application Instructions		 June 9, 2022
  • Maximum funding of $3M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
September 22, 2022 5:00 p.m. Eastern Time

Application:
October 6, 2022 11:59 p.m. Eastern Time

Confidential Letters of Recommendation Submission Deadline:
October 11, 2022 5:00 p.m. Eastern Time
Breakthrough Award Level 3 II (BTA3-2) Program Announcement
Application Instructions		 June 9, 2022 Funding Level 3:
  • Maximum funding of $4M in direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.

Funding Level 3 with Partnering PI Option:

  • Maximum funding of $5M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
August 3, 2022 5:00 p.m. Eastern Time

Invited Application:
November 2, 2022 11:59 p.m. Eastern Time
Breakthrough Award Level 4 II (BTA4-2) Program Announcement
Application Instructions		 June 9, 2022 Funding Level 4 and Funding Level 4 with Partnering PI Option:
  • Maximum funding of $10M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
August 3, 2022 5:00 p.m. Eastern Time

Invited Application:
November 2, 2022 11:59 p.m. Eastern Time
Innovator Award II (INNOV-2) Program Announcement
Application Instructions		 June 9, 2022
  • Maximum funding of $7M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
August 3, 2022 5:00 p.m. Eastern Time

Invited Application:
November 2, 2022 11:59 p.m. Eastern Time

Confidential Letters of Recommendation Submission Deadline:
November 4, 2022 5:00 p.m. Eastern Time
Transformative Breast Cancer Consortium Award II (TBCCA-2) Program Announcement
Application Instructions		 May 24, 2022
  • Maximum funding of $25M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
August 3, 2022 5:00 p.m. Eastern Time

Invited Application:
November 2, 2022 11:59 p.m. Eastern Time

FY21 Chronic Pain Management Research Program (CPMRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Exploration Award (CEA) Program Announcement
Application Instructions 		May 26, 2022
  • The maximum allowable funding for the entire period of performance is $250,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 2 years.
 Pre-Application (Preproposal):
 July 12, 2022 5:00 p.m. Eastern Time

Application:
 October 13, 2022 11:59 p.m. Eastern Time
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions 		May 26, 2022
  • The maximum allowable funding for the entire period of performance is $900,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
 July 12, 2022 5:00 p.m. Eastern Time

Application:
 October 13, 2022 11:59 p.m. Eastern Time
Translational Research Award (TRA) Program Announcement
Application Instructions 		May 26, 2022
  • The maximum allowable funding for the entire period of performance is $1,400,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
 July 12, 2022 5:00 p.m. Eastern Time

Application:
 October 13, 2022 11:59 p.m. Eastern Time

FY22 Combat Readiness – Medical Research Program (CRRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Rapid Development and Translational Research Award (RDTRA) Extramural applicants:
Broad Agency Announcement
General Submission Instructions

Intramural applicants:
Program Announcement Announcement 		May 9, 2022 RDTRA:
  • Maximum funding of $2,200,000 for total costs (to include direct and indirect costs).
  • Maximum period of performance is 2 years.
RDTRA with Option:
  • Maximum funding of $2,200,000 (RDTRA) and 1,000,000 (Option) for total costs (to include direct and indirect costs).
  • Maximum period of performance is 2 years for the RDTRA base award and 1 year for the Option.
 Pre-Application (Preproposal):
 June 23, 2022 5:00 p.m. Eastern Time

Proposal/Application:
 September 14, 2022 11:59 p.m. Eastern Time
DMDRP

FY22 Duchenne Muscular Dystrophy Research Program (DMDRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award (IDA) Program Announcement
Application Instructions 		June 7, 2022
  • Maximum funding of $350,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application (Preproposal):
August 3, 2022 5:00 p.m. Eastern Time (ET)

Application:
November 15, 2022 11:59 p.m. ET
Translational Research Award (TRA) Program Announcement
Application Instructions 		June 7, 2022
  • Maximum funding of $1,250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

Early-Career Partnering PI Option:
  • Maximum funding of $1,350,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal):
August 3, 2022 5:00 p.m. Eastern Time (ET)

Application:
November 15, 2022 11:59 p.m. ET

FY22 Hearing Restoration Research Program (HRRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Focused Research Award (FRA) Program Announcement
Application Instructions 		May 18, 2022 Funding Level 1:
  • Maximum funding of $250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Funding Level 2:
  • Maximum funding of $1,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Funding Level 3:
  • Maximum funding of $1,250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal):
 July 22, 2022
5:00 p.m. Eastern Time

Application:
 November 30, 2022
11:59 p.m. Eastern time

FY22 Kidney Cancer Research Program (KCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Academy of Kidney Cancer Investigators – Early-Career Scholar Award (AKCIECSA) Program Announcement
Application Instructions 		June 16, 2022
  • Maximum funding of $725,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
 September 29, 2022
5:00 p.m. Eastern Time

Application:
 October 20, 2022
11:59 p.m. Eastern Time
Nurse-Initiated Research Award (NIRA) Program Announcement
Application Instructions 		June 16, 2022
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
 September 29, 2022
5:00 p.m. Eastern Time

Application:
 October 20, 2022
11:59 p.m. Eastern Time
Clinical Trial Award (CTA) Program Announcement
Application Instructions 		June 16, 2022
  • Maximum funding of $1,500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Cell Therapy Focus Option:
  • Maximum funding of $2,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
 September 29, 2022
5:00 p.m. Eastern Time

Application:
 October 20, 2022
11:59 p.m. Eastern Time
LCRP

FY22 Lung Cancer Research Program (LCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Translational Research Partnership Award (CTRPA) Program Announcement
Application Instructions 		March 16, 2022
  • Maximum combined funding of $1,200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Letter of Intent):
July 13, 2022 5:00 p.m. Eastern Time

Letter of Intent is required.

Application:
July 27, 2022 11:59 p.m. Eastern Time
LRP

FY22 Lupus Research Program (LRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Award (IA) Program Announcement
Application Instructions 		May 17, 2022
  • The maximum allowable funding for the entire period of performance is $300,000 in total costs (direct plus indirect costs).
  • The maximum period of performance is 2 years.
 Pre-Application (Letter of Intent):
August 16, 2022
5:00 p.m. Eastern Time (ET)

Application:
 September 1, 2022
11:59 p.m. ET
Impact Award (IPA) Program Announcement
Application Instructions 		May 17, 2022
  • The maximum allowable funding for the entire period of performance is $750,000 in total costs (direct plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
August 16, 2022
5:00 p.m. Eastern Time (ET)

Application:
 September 1, 2022
11:59 p.m. ET
Transformative Vision Award (TVA) Program Announcement
Application Instructions 		May 17, 2022
  • The maximum allowable funding for the entire period of performance is $2,500,000 in total costs (direct plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
August 16, 2022
5:00 p.m. Eastern Time (ET)

Application:
 September 1, 2022
11:59 p.m. ET

FY22 Melanoma Research Program (MRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Award (IA) Program Announcement
Application Instructions
 June 3, 2022
  • The maximum allowable funding for the entire period of performance is $500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
July 8, 2022
5:00 p.m. Eastern Time (ET)

Application:
October 5, 2022
11:59 p.m. ET
Melanoma Academy Scholar Award (MASA) Program Announcement
Application Instructions
 June 3, 2022
  • The maximum allowable funding for the entire period of performance is $550,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Letter of Intent):
September 14, 2022
5:00 p.m. ET

Application:
October 5, 2022
11:59 p.m. ET
Mid-Career Accelerator Award (MCAA) Program Announcement
Application Instructions
 June 3, 2022
  • The maximum allowable funding for the entire period of performance is $725,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Letter of Intent):
September 14, 2022
5:00 p.m. ET

Application:
October 5, 2022
11:59 p.m. ET
Team Science Award (TSA) Program Announcement
Application Instructions
 June 3, 2022
  • The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Letter of Intent):
September 14, 2022
5:00 p.m. ET

Application:
October 5, 2022
11:59 p.m. ET
Focused Program Award – Rare Melanomas (FPA) Program Announcement
Application Instructions
 June 3, 2022
  • The maximum allowable funding for the entire period of performance is $2,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
September 14, 2022
5:00 p.m. ET

Application:
October 5, 2022
11:59 p.m. ET
MBRP

FY22 Military Burn Research Program (MBRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Translational Research Award (CTRA) Program Announcement
Application Instructions
 May 26, 2022
  • The maximum allowable funding for the entire period of performance is $2.21 million for total costs (direct costs plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
June 27, 2022 5:00 p.m. Eastern Time

Invitation to Submit an Application:
August 12, 2022

Application:
October 11, 2022 11:59 p.m. Eastern Time
Technology/Therapeutic Development Award (TTDA) Program Announcement
Application Instructions
 May 26, 2022
  • The maximum allowable funding for the entire period of performance is $2.21 million for total costs (direct costs plus indirect costs).
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
June 27, 2022 5:00 p.m. Eastern Time

Invitation to Submit an Application:
August 12, 2022

Application:
October 11, 2022 11:59 p.m. Eastern Time
MSRP

FY22 Multiple Sclerosis Research Program (MSRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award (CTA) Program Announcement
Application Instructions 		April 29, 2022 The FY22 CTA offers two funding levels:

Funding Level 1

  • Maximum funding of $1.6M for total costs.
  • Maximum period of performance is 3 years.

Funding Level 2

  • Maximum funding of $4.5M for total costs.
  • Maximum period of performance is 4 years.
 Pre-Application (Preproposal): June 23, 2022
5:00 p.m. Eastern Time
Application: October 3, 2022 11:59 p.m. Eastern Time
Early Investigator Research Award (EIRA) Program Announcement
Application Instructions 		April 29, 2022
  • Maximum funding of $320,000 for total costs.
  • Maximum period of performance is 2 years.
 Pre-Application (Letter of Intent): August 2, 2022
5:00 p.m. Eastern Time
Confidential Letters of Recommendation: October 6, 2022 5:00 p.m. Eastern Time
Application: October 3, 2022 11:59 p.m. Eastern Time
Exploration - Hypothesis Development Research Award (EHDA) Program Announcement
Application Instructions 		April 29, 2022
  • Maximum funding of $250,000 for total costs.
  • Maximum period of performance is 2 years.
 Pre-Application (Preproposal): June 23, 2022
5:00 p.m. Eastern Time
Application: October 3, 2022 11:59 p.m. Eastern Time
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions 		April 29, 2022
  • Maximum funding of $1M for total costs.
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal): June 23, 2022
5:00 p.m. Eastern Time
Application: October 3, 2022 11:59 p.m. Eastern Time

FY22 Neurofibromatosis Research Program (NFRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award (CTA) Program Announcement
Application Instructions 		April 11, 2022
  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $800,000 in direct costs ($1,000,000 in direct costs if requesting the Qualified Collaborator Option).
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
June 30, 2022 5:00 p.m. Eastern Time

Application:
July 21, 2022 11:59 p.m. ET
Early Investigator Research Award (EIRA) Program Announcement
Application Instructions 		April 11, 2022
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $200,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
June 30, 2022 5:00 p.m. Eastern Time

Application:
July 21, 2022 11:59 p.m. ET

Confidential Letters of Recommendation:
July 26, 2022 5:00 p.m. ET
Exploration - Hypothesis Development Award (EHDA) Program Announcement
Application Instructions 		April 11, 2022
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $100,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
June 30, 2022 5:00 p.m. Eastern Time

Application:
July 21, 2022 11:59 p.m. ET
New Investigator Award (NIA) Program Announcement
Application Instructions 		April 11, 2022
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $450,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
June 30, 2022 5:00 p.m. Eastern Time

Application:
July 21, 2022 11:59 p.m. ET
Synergistic Idea Award (SIA) Program Announcement
Application Instructions 		April 11, 2022
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $2,000,000 in direct costs.
 Pre-Application (Letter of Intent):
June 30, 2022 5:00 p.m. Eastern Time

Application:
July 21, 2022 11:59 p.m. ET
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions 		April 11, 2022
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $525,000 in direct costs.
  • The maximum allowable funding for applications including either the Optional Qualified Collaborator or the NF-OSI Option is $575,000 in direct costs.
  • The maximum allowable funding for applications including both the Optional Qualified Collaborator Option and the NF-OSI Option is $625,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
June 30, 2022 5:00 p.m. Eastern Time

Application:
July 21, 2022 11:59 p.m. ET

FY22 Parkinson’s Research Program (PRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award (EIRA) Program Announcement
Application Instructions 		June 1, 2022
  • Maximum funding of $400,000 for total costs (includes direct and indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application (Letter of Intent):
August 16, 2022
5:00 p.m. Eastern Time

Application: September 1, 2022
11:59 p.m. Eastern Time
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions 		June 1, 2022
  • Maximum funding of $1.2 million (M) for total costs (includes direct and indirect costs).
  • Maximum Period of performance is 3 years.
 Pre-Application (Letter of Intent):
August 16, 2022
5:00 p.m. Eastern Time

Application: September 1, 2022
11:59 p.m. Eastern Time
Synergistic Idea Award (SIA) Program Announcement
Application Instructions 		June 1, 2022
  • Maximum funding of $3 million (M) for total costs (includes direct and indirect costs).
  • Maximum Period of performance is 4 years.
 Pre-Application (Letter of Intent):
August 16, 2022
5:00 p.m. Eastern Time

Application: September 1, 2022
11:59 p.m. Eastern Time

FY22 Pancreatic Cancer Research Program (PCARP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award (IDA) Program Announcement
Application Instructions 		April 26, 2022 Established Single PI Option:
  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

Early-Career Investigator Partnering PI Option:

  • Maximum funding of $650,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal):
July 8, 2022 5:00 p.m. Eastern Time

Application:
October 6, 2022 11:59 p.m. Eastern Time
Translational Research Partnership Award (TRPA) Program Announcement
Application Instructions 		April 26, 2022
  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal):
July 8, 2022 5:00 p.m. Eastern Time

Application:
October 6, 2022 11:59 p.m. Eastern Time

FY22 Peer Reviewed Cancer Research Program (PRCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Behavioral Health Science Award (BHSA) Program Announcement
Application Instructions 		March 31, 2022
  • The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): July 12, 2022 5:00 p.m. Eastern Time

Application: August 2, 2022
11:59 p.m. Eastern Time
Career Development Award (CDA) – Fellow Option Program Announcement
Application Instructions 		March 31, 2022
  • The maximum allowable funding for the entire period of performance is $400,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Letter of Intent): July 12, 2022 5:00 p.m. Eastern Time

Application: August 2, 2022
11:59 p.m. Eastern Time
Career Development Award (CDA) – Virtual Cancer Center Scholar Option Program Announcement
Application Instructions 		March 31, 2022
  • Maximum funding for the entire period of performance is $800,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): July 12, 2022 5:00 p.m. Eastern Time

Application: August 2, 2022
11:59 p.m. Eastern Time
Translational Team Science Award (TTSA) Program Announcement
Application Instructions 		March 31, 2022
  • The maximum allowable funding for the entire period of performance is $2,500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): July 12, 2022 5:00 p.m. Eastern Time

Application: August 2, 2022
11:59 p.m. Eastern Time
Convergent Science Cancer Consortium Development Award (CSCCDA) Program Announcement
Application Instructions 		March 31, 2022
  • The maximum allowable funding for the entire period of performance is $2,500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): August 17, 2022 5:00 p.m. Eastern Time

Application: September 7, 2022
11:59 p.m. Eastern Time

FY22 Prostate Cancer Research Program (PCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award (EIRA) Program Announcement
Application Instructions 		April 5, 2022
  • The maximum allowable funding for the entire period of performance is $300,000 for direct costs.
  • The maximum period of performance is 2 years.
 Pre-Application (LOI):
 July 7, 2022
5:00 p.m. Eastern Time

Application:
July 28, 2022
11:59 p.m. Eastern Time

Letters of Recommendation:
August 2, 2022
5:00 p.m. Eastern Time
Physician Research Award (PRA) Program Announcement
Application Instructions 		April 5, 2022
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • The maximum period of performance is 4 years.
 Pre-Application (LOI):
 July 7, 2022
5:00 p.m. Eastern Time

Application:
July 28, 2022
11:59 p.m. Eastern Time

Letters of Recommendation:
August 2, 2022
5:00 p.m. Eastern Time
Translational Science Award (TSA) Program Announcement
Application Instructions 		April 5, 2022
  • The maximum allowable funding for the entire period of performance is $900,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-Application (LOI):
 August 4, 2022
5:00 p.m. Eastern Time

Application:
August 25, 2022
11:59 p.m. Eastern Time
Health Disparity Research Award (HDRA) Program Announcement
Application Instructions 		April 5, 2022
  • The maximum allowable funding for the entire period of performance is $900,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-Application (LOI):
 August 4, 2022
5:00 p.m. Eastern Time

Application:
August 25, 2022
11:59 p.m. Eastern Time
Idea Development Award (IDA) Program Announcement
Application Instructions 		April 5, 2022
  • The maximum allowable funding for the entire period of performance is $900,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-Application (LOI):
 July 7, 2022
5:00 p.m. Eastern Time

Application:
July 28, 2022
11:59 p.m. Eastern Time
Data Science Award (DSA) Program Announcement
Application Instructions 		April 5, 2022
  • The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-Application (LOI):
 August 4, 2022
5:00 p.m. Eastern Time

Application:
August 25, 2022
11:59 p.m. Eastern Time

FY22 Rare Cancers Research Program (RCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Concept Award (CA) Program Announcement
Application Instructions 		April 21, 2022
  • Maximum funding of $100,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 1 year.
 Pre-Application (Letter of Intent):
July 18, 2022
5:00 p.m. Eastern Time (ET)

Application:
August 29, 2022
11:59 p.m. ET
Idea Development Award (IDA) Program Announcement
Application Instructions 		April 21, 2022
  • Maximum funding of $350,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal):
June 22, 2022
5:00 p.m. Eastern Time (ET)

Application:
September 30, 2022
11:59 p.m. ET
Resource and Community Development Award (RCDA) Program Announcement
Application Instructions 		April 21, 2022
  • Maximum funding of $600,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal):
June 22, 2022
5:00 p.m. Eastern Time (ET)

Application:
September 30, 2022
11:59 p.m. ET

FY22 Reconstructive Transplant Research Program (RTRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions 		June 15, 2022 Single PI:
  • Maximum funding of $1 million (M) for total costs (direct plus indirect costs).
  • Maximum period of performance is 3 years.
Multiple PI Option:
  • Maximum total funding of $1.5M for total costs (direct plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal):
July 27, 2022
5:00 p.m. Eastern Time (ET)

Application:
October 19, 2022
11:59 p.m. ET
Advanced Technology Development Award (ATDA) Program Announcement
Application Instructions 		June 15, 2022 Single PI:
  • Maximum funding of $1M for total costs (direct plus indirect costs).
  • Maximum period of performance is 3 years.
Multiple PI Option:
  • Maximum total funding of $1.5M for total costs (direct plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal):
July 27, 2022
5:00 p.m. Eastern Time (ET)

Application:
October 19, 2022
11:59 p.m. ET
Concept Award (CA) Program Announcement
Application Instructions 		June 15, 2022
  • Maximum funding of $200,000 for total costs.
  • Maximum period of performance is 18 months.
 Pre-Application (Letter of Intent):
September 28, 2022
5:00 p.m. ET

Application:
October 19, 2022
11:59 p.m. ET

FY22 Tuberous Sclerosis Complex Research Program (TSCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Exploration Hypothesis Development Award (EHDA) Program Announcement
Application Instructions 		March 31, 2022
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $150,000 in direct costs.
  • Indirect costs may be proposed in accordance With the institution's negotiated rate agreement.
 Pre-Application (Letter of Intent): June 30, 2022
5:00 p.m. Eastern Time (ET)

Application:
July 28, 2022 11:59 p.m. ET
Idea Development Award (IDA) Program Announcement
Application Instructions 		March 31, 2022
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $500,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
 Pre-Application (Letter of Intent): June 30, 2022
5:00 p.m. Eastern Time (ET)

Application:
July 28, 2022 11:59 p.m. ET
Clinical Translational Research Award (CTRA) Program Announcement
Application Instructions 		March 31, 2022
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $1,000,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
 Pre-Application (Letter of Intent): June 30, 2022
5:00 p.m. Eastern Time (ET)

Application:
July 28, 2022 11:59 p.m. ET

FY22 Vision Research Program (VRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award (CTA) Program Announcement
Application Instructions 		May 12, 2022
  • The maximum allowable funding for the entire period of performance is $1,600,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
July 15, 2022
5:00 p.m. Eastern Time

Application: November 9, 2022
11:59 p.m. Eastern Time
Focused Translational Team Science Award (FTTSA) Program Announcement
Application Instructions 		May 12, 2022
  • The maximum allowable funding for the entire period of performance is $4,000,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
July 15, 2022
5:00 p.m. Eastern Time

Application: November 9, 2022
11:59 p.m. Eastern Time
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions 		May 12, 2022 Funding Level 1:
  • The maximum allowable funding for the entire period of performance is $260,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 2 years.

Funding Level 2:

  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
July 15, 2022
5:00 p.m. Eastern Time

Application: November 9, 2022
11:59 p.m. Eastern Time
Translational Research Award (TRA) Program Announcement
Application Instructions 		May 12, 2022
  • The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
July 15, 2022
5:00 p.m. Eastern Time

Application: November 9, 2022
11:59 p.m. Eastern Time

CDMRP

Privacy Notice · External Links/Product Disclaimers · Research Programs · Funding Opportunities · Consumer Involvement · Search Awards · About Us

CDMRP © 2015

location icon

1077 Patchel Street Fort Detrick, MD 21702-5024

telephone icon

(301) 619-7071

About Us The CDMRP originated in 1992 via a Congressional appropriation to foster novel approaches to biomedical research in response to the expressed needs of its stakeholders-the American public, the military, and Congress.

- MRDC Family -

CDMRP | TATRC | USAARL | USAISR | USAMMDA | USAMRAA | USAMRICD | USAMRIID | USARIEM | WRAIR